Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hematology
Pharma
AbbVie scores FDA green light for another ImmunoGen asset
AbbVie's ImmunoGen buyout continues to pay off, thanks to a new FDA nod for an antibody-drug conjugate for a rare form of blood cancer.
Fraiser Kansteiner
May 28, 2026 7:27am
Rising Stars: Kristen Raimondi on creating new hope for patients
Oct 22, 2025 6:00am
JPM24: Roche touts its rebound in hematology, led by Hemlibra
Jan 9, 2024 4:26pm
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
May 10, 2023 11:25am
Argenx builds clinical case for 'pipeline in a product' efgart
Dec 10, 2022 11:30am
Takeda, BMS-BeiGene, Samsung and more—Fierce Pharma Asia
Oct 15, 2021 9:00am
